Drug Profile
Bamet R2
Alternative Names: Cisplatin cholylglycinate - controlled release; Cisplatin cholylglycinate - University of SalamancaLatest Information Update: 23 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Platinum complexes
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer